We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
13.50 | 1.04% | 1,313.50 | 1,313.50 | 1,314.00 | 1,313.50 | 1,300.00 | 1,300.00 | 828,264 | 11:26:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.04 | 53.89B |
Date | Subject | Author | Discuss |
---|---|---|---|
03/10/2024 11:50 | Unfortunately I don't think it'll be put to bed for a while yet. The US is such a litigious place and as long as lawyers can juice more fees out of it then it may hang over GSK for years | dplewis1 | |
03/10/2024 08:54 | What's irritating is that the whole Zantac saga has been a drag on the stock for over 2 years now. Hopefully a successful appeal against the Delaware court decision back in June will be a pivotal moment in the resolution of it. | rikky72 | |
03/10/2024 08:31 | Nothing wrong with the management. It's Zantac holding back the stock. Outside of Zantac the company is doing well and is significantly undervalued | dope007 | |
03/10/2024 08:29 | Gotta be vulnerable to a bid at some point. Maybe then they'll get some decent management | spoole5 | |
03/10/2024 07:33 | Looks like I need to make another top up here down 1.6% this morning | paulstills | |
03/10/2024 07:33 | Jefferies cuts target price to 2000p from 2100p | dplewis1 | |
02/10/2024 16:30 | Another slice of R&D cost going onto the balance sheet. | alphorn | |
02/10/2024 14:27 | In a notable transaction, has recently increased its stake in Wave Life Sciences Ltd . (NASDAQ:WVE). The acquisition involved the purchase of 2,791,930 ordinary shares at a price of $8.00 per share, amounting to a total investment of $22.3 million. This strategic move by GSK plc, as it further solidifies its position as a significant shareholder in the biotechnology firm. The transaction was carried out on September 27, 2024, and was officially filed on October 1. | tradermichael | |
02/10/2024 12:50 | Trader, this case in California, is a critical one for GSK, this will decide the fate of this company. | hjs | |
02/10/2024 09:15 | The first Zantac trial in California is slated to kick off with jury selection on next week in Alameda County Superior Court in Oakland. the trial is expected to begin on October 7, 2024. The outcome of this case will be closely watched as it may set the tone for future Zantac lawsuits across the country. | tradermichael | |
01/10/2024 10:13 | Share price lower now than 1998, gotta love U.K. shares haha, what a dog of an index. In the next market meltdown these are probably back to 12 quid, for a dividend that’s less than risk free T bills. | porsche1945 | |
01/10/2024 09:16 | If you read about the Supreme Court decision to grant the appeal it seems that such appeals are only granted when there is a serious doubt over the original decision. So success seems more likely than not but when will it be heard? This year, next year? | rikky72 | |
01/10/2024 08:48 | This and a couple of other dividends have just gone into a few more here | dope007 | |
01/10/2024 08:43 | Watching this closely | pander45 | |
01/10/2024 08:39 | From where!! | spoole5 | |
01/10/2024 08:27 | ... and the share price will go up substantially! | tradermichael | |
01/10/2024 07:44 | I don't believe the CEO can be held responsible for the Zantac 'overhang' which is the main factor keeping the price as low as it is. To a large extent the market is already pricing in defeat. In time this will be resolved one way or the other. | patientcapital | |
01/10/2024 07:36 | Awful share. Emma should be long gone by now. | spoole5 | |
01/10/2024 07:31 | Back in this morning at sub 1500 A small buy to keep my powder dry but longer term at these levels there is money to be made I think. Good luck all 👍🏻 | tuftymatt | |
01/10/2024 07:21 | Barclays cuts target price to 1550p from 1650p | dplewis1 | |
27/9/2024 07:29 | Added a few at 1529p for the long term. One more add and that will be it | dope007 | |
26/9/2024 15:02 | Be good for my dividend investment but again today look at the comical state of UK mkts versus the rest | dope007 | |
26/9/2024 14:54 | And into the 1400s we go | spoole5 | |
25/9/2024 15:16 | My LGEN dividend arrives Friday and will invest it here if the price remains down here | dope007 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions